Dr. Michael Kluk, MD

• Molecular Genetic Pathology

• Hematopathology

• Anatomic & Clinical Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Brigham And Womens Hospital

  Fellowship Hospital, 2010

• Massachusetts General Hospital

  Fellowship Hospital, 2009

• Yale New Haven Hospital

  Residency Hospital, 2008

• University Of Connecticut School Of Medicine

  Medical School, 2004

• Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke, 2015-08-05

• Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas, 2012-04-12

• Characterization of activating mutations of NOTCH3 in T cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies, 2016-05-09

• MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma, 2013-04-22

• Sphingosine-1-Phosphate Receptor 1 in Classical Hodgkin Lymphoma: Assessment of Expression and Role in Cell Migration, 2013-02-18

• Cyclin C is a haploinsufficient tumor suppressor, 2014-10-26

• NOTCH1mutations occur early during cutaneous squamous cell carcinogenesis, 2014-03-24

• An epigenetic mechanism of resistance to targeted therapy in T-cell acute lymphoblastic leukemia, 2014-03-02